VR Adviser as of Sept. 30, 2023
Portfolio Holdings for VR Adviser
VR Adviser holds 37 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apogee Therapeutics (APGE) | 19.0 | $181M | 8.5M | 21.30 | |
| Rayzebio | 9.4 | $89M | 4.0M | 22.20 | |
| Miragen Therapeutics (VRDN) | 5.0 | $47M | 3.1M | 15.34 | |
| Cogent Biosciences (COGT) | 4.8 | $46M | 4.7M | 9.75 | |
| Taysha Gene Therapies Com Shs (TSHA) | 4.8 | $46M | 14M | 3.16 | |
| Merus N V (MRUS) | 4.3 | $41M | 1.7M | 23.58 | |
| Enliven Therapeutics (ELVN) | 4.2 | $40M | 3.0M | 13.66 | |
| 4d Molecular Therapeutics In (FDMT) | 4.0 | $38M | 3.0M | 12.73 | |
| Pharvaris N V (PHVS) | 3.4 | $33M | 1.6M | 20.87 | |
| Cabaletta Bio (CABA) | 3.2 | $30M | 2.0M | 15.22 | |
| Kalvista Pharmaceuticals (KALV) | 3.0 | $28M | 2.9M | 9.63 | |
| Gh Research Ordinary Shares (GHRS) | 2.9 | $28M | 2.7M | 10.05 | |
| Hillevax (HLVX) | 2.9 | $27M | 2.0M | 13.45 | |
| Savara (SVRA) | 2.9 | $27M | 7.2M | 3.78 | |
| Rhythm Pharmaceuticals (RYTM) | 2.6 | $25M | 1.1M | 22.93 | |
| Ambrx Biopharma Sponsored Ads | 2.5 | $24M | 2.1M | 11.50 | |
| Travere Therapeutics (TVTX) | 2.5 | $24M | 2.6M | 8.94 | |
| Dyne Therapeutics (DYN) | 2.1 | $20M | 2.2M | 8.96 | |
| Celcuity (CELC) | 2.0 | $19M | 2.1M | 9.14 | |
| Terns Pharmaceuticals (TERN) | 1.6 | $16M | 3.1M | 5.03 | |
| Mersana Therapeutics (MRSN) | 1.5 | $14M | 11M | 1.27 | |
| Applied Therapeutics (APLT) | 1.5 | $14M | 5.7M | 2.49 | |
| Oric Pharmaceuticals (ORIC) | 1.4 | $13M | 2.1M | 6.05 | |
| Dianthus Therapeutics (DNTH) | 1.3 | $13M | 928k | 13.67 | |
| Adverum Biotechnologies | 1.0 | $9.9M | 6.6M | 1.50 | |
| Praxis Precision Medicines I | 1.0 | $9.1M | 5.3M | 1.71 | |
| Acelyrin (SLRN) | 0.9 | $8.8M | 864k | 10.17 | |
| Trevi Therapeutics (TRVI) | 0.8 | $7.5M | 3.4M | 2.18 | |
| Aclaris Therapeutics (ACRS) | 0.8 | $7.1M | 1.0M | 6.85 | |
| Milestone Pharmaceuticals (MIST) | 0.7 | $6.8M | 2.2M | 3.10 | |
| Pliant Therapeutics (PLRX) | 0.5 | $5.0M | 289k | 17.34 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.5 | $4.5M | 515k | 8.80 | |
| Aeglea Biotherapeutics | 0.4 | $3.6M | 295k | 12.25 | |
| Lyra Therapeutics (LYRA) | 0.4 | $3.6M | 924k | 3.91 | |
| Olema Pharmaceuticals (OLMA) | 0.1 | $952k | 77k | 12.35 | |
| Rallybio Corp (RLYB) | 0.1 | $905k | 269k | 3.37 | |
| Affimed Therapeutics B V | 0.1 | $683k | 1.4M | 0.48 |
